For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.

Our stock screening tool has pinpointed HAEMONETICS CORP/MASS (NYSE:HAE) as a growth stock that isn't overvalued. NYSE:HAE is excelling in various growth indicators while maintaining a solid financial footing. Furthermore, it remains attractively priced. Let's delve into the specifics below.

Growth Analysis for NYSE:HAE

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:HAE has earned a 7 for growth:

• HAE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.30%, which is quite impressive.
• HAE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.25% yearly.
• HAE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.47%.
• The Earnings Per Share is expected to grow by 18.77% on average over the next years. This is quite good.
• HAE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.94% yearly.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
• The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Evaluating Valuation: NYSE:HAE

To assess a stock's valuation, ChartMill utilizes a Valuation Rating on a scale of 0 to 10. This comprehensive assessment considers various valuation aspects, comparing price to earnings and cash flows, while factoring in profitability and growth. NYSE:HAE has achieved a 7 out of 10:

• Based on the Price/Earnings ratio, HAE is valued cheaply inside the industry as 85.20% of the companies are valued more expensively.
• 86.73% of the companies in the same industry are more expensive than HAE, based on the Price/Forward Earnings ratio.
• Based on the Enterprise Value to EBITDA ratio, HAE is valued cheaper than 85.71% of the companies in the same industry.
• HAE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HAE is cheaper than 85.71% of the companies in the same industry.
• The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• HAE has an outstanding profitability rating, which may justify a higher PE ratio.
• A more expensive valuation may be justified as HAE's earnings are expected to grow with 17.66% in the coming years.

Health Analysis for NYSE:HAE

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:HAE has received a 5 out of 10:

• HAE has an Altman-Z score of 3.42. This indicates that HAE is financially healthy and has little risk of bankruptcy at the moment.
• The Altman-Z score of HAE (3.42) is better than 67.86% of its industry peers.
• The Debt to FCF ratio of HAE (6.76) is better than 79.08% of its industry peers.
• HAE has a Current Ratio of 2.92. This indicates that HAE is financially healthy and has no problem in meeting its short term obligations.

Analyzing Profitability Metrics

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NYSE:HAE scores a 8 out of 10:

• The Return On Assets of HAE (5.75%) is better than 84.18% of its industry peers.
• With an excellent Return On Equity value of 13.41%, HAE belongs to the best of the industry, outperforming 88.78% of the companies in the same industry.
• The Return On Invested Capital of HAE (7.70%) is better than 87.24% of its industry peers.
• The 3 year average ROIC (5.44%) for HAE is below the current ROIC(7.70%), indicating increased profibility in the last year.
• The Profit Margin of HAE (9.96%) is better than 83.67% of its industry peers.
• In the last couple of years the Profit Margin of HAE has grown nicely.
• With an excellent Operating Margin value of 15.69%, HAE belongs to the best of the industry, outperforming 87.76% of the companies in the same industry.
• In the last couple of years the Operating Margin of HAE has grown nicely.
• In the last couple of years the Gross Margin of HAE has grown nicely.

More Affordable Growth stocks can be found in our Affordable Growth screener.

Check the latest full fundamental report of HAE for a complete fundamental analysis.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.